ENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER
Tarih
2020Yazar
Randall, L.
Marth, C.
Vulsteke, C.
Rubio, M. Jesus
Makker, V.
Braicu, I.
McNeish, I.
Madry, R.
Ayhan, A.
Hasegawa, K.
Wu, X.
Dutta, L.
Xu, C.
Keefe, S.
Lee, J.
Pignata, S.